AstraZeneca Plc has expanded its oncology footprint with a deal to acquire a German diagnostics company, Definiens GmbH, and a separate agreement to conduct clinical trials of new combination treatments for cancer with Pharmacyclics Inc of the US. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
